← All trials
NCT06239298
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 10, 2024
- Primary completion
- Mar 31, 2026
- Completion date
- May 31, 2026
- First posted
- Feb 2, 2024
- Last posted
- Jun 14, 2024
- Enrollment
- 130
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Suzhou Zelgen Biopharmaceuticals Co.,LtdLead sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,LtdOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.